1,687
Views
23
CrossRef citations to date
0
Altmetric
Laboratory Study

Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy

, , , , &
Pages 364-370 | Received 11 Jul 2017, Accepted 06 Mar 2018, Published online: 30 Apr 2018

References

  • Lai KN, Tang SC, Schena FP, et al. IgA nephropathy. Nat Rev Dis Primers. 2016;2:16001.
  • KDIGO. Chapter 10: Immunoglobulin A nephropathy. Kidney Int Suppl. 2012;2:209–217.
  • Qiu H, Fan W, Fu P, et al. General acteoside of rehmanniae leaves in the treatment of primary chronic glomerulonephritis: a randomized controlled trial. Afr J Trad Compl Alt Med. 2013;10:109–115.
  • Zhao M, Qian D, Liu P, et al. Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract. Biomed Chromatogr. 2015;29:1842–1848.
  • Zheng Q, Yang T, Fang L, et al. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis. BMC Complement Altern Med. 2015;15:60.
  • Meng T, Li X, Ao X, et al. Hemolytic Streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells. PLoS One. 2014;29:e108723.
  • Jia L, Wu C. The biology and functions of Th22 cells. Adv Exp Med Biol. 2014;841:209–230.
  • Xiao C, Zhou Q, Li X, et al. Differentiation and recruitment of IL-22-producing helper T cells in lgA nephropathy. Am J Transl Res. 2016;8:3872–3882.
  • Lai KN, Leung JC, et al. Activation of podocytes by mesangial derived TNF-α: glomerulo–podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol. 2008;294:945–955.
  • Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–338.
  • Wang B, Komers R, Carew R, et al. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol. 2012;23:252–265.
  • Yuzawa Y, Yamamoto R, Takahashi K, et al. Evidence-based clinical practice guidelines for IgA nephropathy 2014. Clin Exp Nephrol. 2016;20:511–535.
  • Qiu H, Fu P, Fan W, et al. Treatment of primary chronic glomerulonephritis with Rehmannia glutinosa acteosides in combination with the angiotensin receptor blocker irbesartan: a randomized controlled trial. Phytother Res. 2014;28:132–136.
  • Sadakane C, Hattori T, Koseki J, et al. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice. Biol Pharm Bull. 2009;32:1728–1733.
  • Saegusa Y, Sadakane C, Koseki J, et al. (E) - N - [(3,4 - dimethoxyphenethyl)] - N - methyl - 3 - (3-pyridyl) - 2 - propenamide (TJN - 331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice. Clin Exp Nephrol. 2010;14:528–535.
  • Wei Y, Luo QL, Sun J, et al. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model. J Ethnopharmacol. 2015;164:368–377.
  • Maruyama S, Gohda T, Suzuki Y, et al. Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy. Kidney Res Clin Pract. 2016;35:233–236.
  • Grigore A, Colceru-Mihul S, Litescu S, et al. Correlation between polyphenol content and anti-inflammatory activity of Verbascum phlomoides (mullein). Pharm Biol. 2013;51:925–929.
  • You Q, Yin X, Zhao Y. Enzyme assisted extraction of polysaccharides from the fruit of Cornus officinalis. Carbohydr Polym. 2013;98:607–610.
  • Ebefors K, Liu P, Lassén E, et al. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1. BMC Nephrol. 2016;17:40.
  • Yoou MS, Kim HM, Jeong HJ. Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2. Int Immunopharmacol. 2015;26:23–29.
  • Motojima H, Villareal MO, Iijima R, et al. Acteoside inhibits type Ι allergy through the down-regulation of Ca/NFAT and JNK MAPK signaling pathways in basophilic cells. J Nat Med. 2013;67:790–798.
  • Zhu L, Zhang Q, Shi S, et al. Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy. PLoS One. 2013;8:e73425.
  • Brembilla NC, Dufour AM, Alvarez M, et al. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma. Ann Rheum Dis. 2016;75:1697–1705.
  • Sziksz E, Pap D, Lippai R, et al. Fibrosis related inflammatory mediators: Role of the IL-10 cytokine family. Mediators Inflamm. 2015;2015:764641.
  • Weathington NM, Snavely CA, Chen BB, et al. Glycogen synthase kinase-3β stabilizes the interleukin (IL)-22 receptor from proteasomal degradation in murine lung epithelia. J Biol Chem. 2014;289:17610–17619.